COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 869: Articles 8681-8690  | Next

How did the COVID-19 Pandemic impact self-reported cancer screening rates in 12 Midwestern states?
Semprini, J.
10.1101/2022.04.13.22273837 — Posted: 2022-04-18
Effectiveness of Four Vaccines in Preventing SARS-CoV-2 Infection in Kazakhstan
NABIROVA, D., Horth, R., Smagul, M., Nukenova, G., Yesmagambetova, A., Singer, D., Henderson, A., Tsoy, A.
10.1101/2022.04.14.22273868 — Posted: 2022-04-18
A comparative analysis of pediatric mental health-related emergency department utilization in Montreal, Canada before and during the COVID-19 pandemic
Beaudry, G., Drouin, O., Gravel, J., Smyrnova, A., Bender, A., Orri, M., Geoffroy, M.-C., Chadi, N.
10.1101/2022.04.18.22273970 — Posted: 2022-04-18
Multi-faceted analysis of COVID-19 epidemic in the Republic of Korea considering Omicron variant: Mathematical modeling-based study
Ko, Y., Mendoza, V. M., Mendoza, R., Seo, Y. B., Lee, J., Lee, J., Kwon, D., Jung, E.
10.1101/2022.04.15.22273907 — Posted: 2022-04-18
Previous SARS-CoV-2 infection or a third dose of vaccine elicited cross-variant neutralizing antibodies in vaccinated solid organ transplant recipients
Chang, C.-C., Vlad, G., Vasilescu, E. R., Li, P., Husain, S. A., Silvia, E. A., Cohen, D. J., Ratner, L. E., Sun, W.-Z., Mohan, S., Suciu-Foca, N.
10.1101/2022.04.13.22273829 — Posted: 2022-04-18
Comprehensive analyses reveal the impacts of vaccination status and physiological variables in early infection on viral persistence in COVID-19 patients: a retrospective single-center cohort study
Tian, X., Zhang, Y., Wang, W., Fang, F., Zhang, W., Wan, Y., Zhu, Z.
10.1101/2022.04.14.22273860 — Posted: 2022-04-18
Association of Covid-19 Vaccine Hesitancy with Demographics, Mental Health, and Disability
Bhattacharyya, A., Singh, S., Sakshi, S., Seth, A., Rai, S.
10.1101/2022.04.13.22273843 — Posted: 2022-04-18
The methodologies to assess the effects of non-pharmaceutical interventions during COVID-19: a systematic review
Banholzer, N., Lison, A., Ozcelik, D., Stadler, T., Feuerriegel, S., Vach, W.
10.1101/2022.04.14.22273858 — Posted: 2022-04-18
Genetic risk and incident venous thromboembolism in middle-aged and older adults following 1 Covid-19 vaccination
Xie, J., Prats-Uribe, A., Gordillo Maranon, M., Strauss, V. Y., Gill, D., PRIETO-ALHAMBRA, D.
10.1101/2022.04.14.22273865 — Posted: 2022-04-18
COVID-19 vaccine effectiveness against severe disease from the Omicron BA.1 and BA.2 subvariants: surveillance results from southern Sweden, December 2021 to March 2022
Bjork, J., Bonander, C., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Inghammar, M., Kahn, F.
10.1101/2022.04.14.22273896 — Posted: 2022-04-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).